PLGA公司
材料科学
微流控
肺表面活性物质
微球
纳米技术
体积流量
生物医学工程
色谱法
化学工程
化学
纳米颗粒
量子力学
医学
物理
工程类
作者
Elham Jafarifar,Marziyeh Hajialyani,Masoud Rahimi,Masoud Rahimi,Yalda Shokoohinia,Ali Fattahi
标识
DOI:10.1080/10837450.2016.1221426
摘要
The aim of the present study is to prepare risperidone-loaded poly lactic-co-glycolic acid (PLGA) microspheres within microfluidic system and to achieve a formulation with uniform size and monotonic and reproducible release profile. In comparison to batch method, T-junction and serpentine chips were utilized and optimizing study was carried out at different processing parameters (e.g. PLGA and surfactant concentration and flow rates ratio of outer to inner phase). The computational fluid dynamic (CFD) modeling was performed, and loading and release study were carried out. CFD simulation indicates that increasing the flow rate of aqueous phase cause to decrease the droplet size, while the change in size of microspheres did not follow a specific pattern in the experimental results. The most uniform microspheres and narrowest standard deviation (66.79 μm ± 3.32) were achieved using T-junction chip, 1% polyvinylalcohol, 1% PLGA and flow rates ratio of 20. The microfluidic-assisted microspheres were more uniform with narrower size distribution. The release of risperidone from microspheres produced by the microfluidic method was more reproducible and closer to zero-order kinetic model. The release profile of formulation with 2:1 drug-to-polymer ratio was the most favorable release, in which 41.85% release could be achieved during 24 days.
科研通智能强力驱动
Strongly Powered by AbleSci AI